Viropharma Picovir Oral Contraceptive Study Data Expected This Summer
Executive Summary
Viropharma expects to have data from a Phase I drug interaction study of oral contraceptives and Picovir (pleconaril) in two to four months
You may also be interested in...
Schering To Fund Picovir Studies Under Development Deal With ViroPharma
Schering-Plough will decide whether to fund additional development of ViroPharma's Picovir after assessing preclinical and Phase I data for an intranasal formulation of the common cold treatment in mid-2004
Schering To Fund Picovir Studies Under Development Deal With ViroPharma
Schering-Plough will decide whether to fund additional development of ViroPharma's Picovir after assessing preclinical and Phase I data for an intranasal formulation of the common cold treatment in mid-2004
Aventis DiaPep277 Phase III Discussion Focuses On Endpoint; Picovir Dropped
Aventis/Peptor DiaPep277 will enter Phase III trials following agreement with FDA on appropriate clinical endpoints for the diabetes agent